Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma Ads (NQ: ASND )

156.90 USD -5.11 (-3.15%)
Streaming Delayed Price Updated: 3:18 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ascendis Pharma Ads

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
Shanghai 's Visen Pharma closed a $150 million Series B financing to develop novel endocrine drugs in a round led by Sequoia China . In 2018, Visen was formed by Ascendis Pharma A/S of Denmark and an... 
From ChinaBio® Today
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China, announced today the... 
From PR Newswire
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
From GlobeNewswire News Releases
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
- TransCon ™ C-Type Natriuretic Peptide (CNP), an investigational once-weekly long-acting prodrug of CNP, is ready for Phase 2 Clinical Trial in China - 
From PR Newswire
Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Final Trading Session Of 2020
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade on the last trading day of 2020. Markets closed ... 
Tags Futures Pre/Market Outlook AZN
From Benzinga
5 Stocks To Watch For December 31, 2020
Some of the stocks that may grab investor focus today are: S&P Dow Jones Indices reported that Enphase Energy Inc. (NASDAQ: ... 
Tags ASND FCPT News
From Benzinga
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program
From GlobeNewswire News Releases
Benzinga's Top Upgrades, Downgrades For December 17, 2020
Upgrades For CAE Inc (NYSE:CAE), Bank of America upgraded the previous rating of Neutral to Buy. CAE earned $0.10 in the ... 
Tags MDB STL INDB
From Benzinga
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EIDX ARVN STOK
From Benzinga
Ascendis Pharma A/S Announces Planned Board Transition
From GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ... 
Tags HLIO MEOH R
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ... 
Tags CCJ TGTX AHCO
From Benzinga
Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
From GlobeNewswire News Releases
Ascendis Pharma Earns Relative Strength Rating Upgrade
Ascendis Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
10 Biggest Price Target Changes For Friday
Raymond James raised the price target for Costco Wholesale Corporation (NASDAQ: COST) from $365 to $405. Costco shares rose 0.1% to ... 
Tags Small Cap Price Target Changes DRI
From Benzinga
Ascendis Pharma A/S to Host Virtual Oncology R&D Day on Friday, November 20
From GlobeNewswire News Releases
Recap: Ascendis Pharma Q3 Earnings
Shares of Ascendis Pharma (NASDAQ:ASND) were flat in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Earnings Benzinga ASND
From Benzinga
Ascendis Pharma A/S Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CYCC ESPR CODX
From Benzinga
Earnings Scheduled For November 11, 2020
Companies Reporting Before The Bell • Air Products & Chemicals (NYSE:APD) is projected to report quarterly ... 
Tags NEPT BEDU News
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags NAVB IOVA LIFE
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CHRS VRTX EXEL
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
This morning 118 companies reached new 52-week highs. Noteworthy Points: Alphabet (NASDAQ: GOOG) was the company with ... 
Tags RCM FSV ZEN
From Benzinga
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
From GlobeNewswire News Releases
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SPRB GH BVXV
From Benzinga
Human Growth Hormone Deficiency (GHD) Drugs Market : Facts, Figures and Analytical Insights 2020-2023
Harrisburg, NC -- (SBWIRE) -- 10/27/2020 -- The Human Growth Hormone Deficiency (GHD) Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry... 
From SBWire - Latest Press Releases
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.